Merck, IBM and Battelle have signed up to partner with GE Healthcare on a new vaccine plant that has been proposed by the University of Pittsburgh Medical Center. The vaccine facility backers want to build a state-of-the-art facility that can respond on an emergency basis to bioterror attacks. Merck would contribute its drug-development expertise, with IBM handling IT and Battelle doing the pre-clinical work and research. Story